- Author:
Ki-Yong AN
1
;
Jihee MIN
;
Dong Hoon LEE
;
Dong-Woo KANG
;
Kerry S. COURNEYA
;
Justin Y. JEON
Author Information
- Publication Type:Review Article
- From:Yonsei Medical Journal 2024;65(6):315-323
- CountryRepublic of Korea
- Language:EN
- Abstract: Exercise has long been recognized as an important component of treatment for various diseases. However, the benefits and risks of exercise interventions must be carefully evaluated to ensure the former outweighs the latter. As cancer patients undergo diverse treatment modalities with distinct objectives, a systematic approach partitioning the cancer journey into distinct phases is necessary to inform tailored exercise prescriptions. This narrative review summarizes exercise benefits and mechanisms for cancer patients and survivors across four distinct survivorship periods—before surgery, after surgery and before adjuvant treatment, during nonsurgical treatment (adjuvant and neoadjuvant), and during extended survival. In summary, exercise reduces the risks of complications and declines in physical functioning while improving fatigue, quality of life, and the ability to manage treatment effects. Although additional research is warranted, existing evidence is sufficient to integrate exercise into clinical oncology practice and cancer survivorship programs.